HopeStage
Back to all studies
TerminatedNCT02189915

Open-Label Creatine Study for Female Meth Users

Medication studyAges 13–55United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 13 years to 55 years.

Listed locations
Salt Lake CitySee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateJanuary 2012
Recruitment status
Terminated
Enrollment listed in the registry
14
Sponsor
Perry Renshaw
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Locations
United States
Age range
From 13 Years to 55 Years
Official registry ID
NCT02189915
Official title
Show the full official title

Open-Label Creatine Monohydrate Supplementation in Depressed Female Methamphetamine Users

Recruitment & locations

Terminated

Salt Lake City

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Perry Renshaw.

Does this study involve medication?

Yes. The study involves medication, including Creatine monohydrate.

Who can participate?

Listed age limits: 13 years to 55 years.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies